Steven C. Gilman

436 total citations
15 papers, 364 citations indexed

About

Steven C. Gilman is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Steven C. Gilman has authored 15 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Immunology. Recurrent topics in Steven C. Gilman's work include Radiopharmaceutical Chemistry and Applications (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven C. Gilman is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Inflammatory mediators and NSAID effects (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Steven C. Gilman collaborates with scholars based in United States and South Korea. Steven C. Gilman's co-authors include Joseph Chang, Joanne Uhl, Alan J. Lewis, Eugene Mochan, Richard P. Carlson, Mary Brummet, Kristin M. Leiferman, Thasia Woodworth, Robert P. Schleimer and Syed Shahabuddin and has published in prestigious journals such as The Journal of Immunology, Transplantation and Journal of Immunological Methods.

In The Last Decade

Steven C. Gilman

15 papers receiving 332 citations

Peers

Countries citing papers authored by Steven C. Gilman

Since Specialization

Citations

This map shows the geographic impact of Steven C. Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven C. Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven C. Gilman more than expected).

Fields of papers citing papers by Steven C. Gilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven C. Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven C. Gilman. The network helps show where Steven C. Gilman may publish in the future.

Co-authorship network of co-authors of Steven C. Gilman

This figure shows the co-authorship network connecting the top 25 collaborators of Steven C. Gilman. A scholar is included among the top collaborators of Steven C. Gilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven C. Gilman. Steven C. Gilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Rifalazil and Other Benzoxazinorifamycins in the Treatment of Chlamydia‐Based Persistent Infections 2007 ·Archiv der Pharmazie ·David M. Rothstein, John van Duzer, Andrew Sternlicht, Steven C. Gilman	13
2	The anti-tumor activity of anti-CTLA-4 is mediated through its induction of IFNγ 2001 ·Cancer Immunology Immunotherapy ·Timothy Paradis, Eugenia Floyd, (unknown), (unknown), Brandon L. Brunson, Eileen A. Elliott, Steven C. Gilman, Ronald P. Gladue	34
3	Cutaneous Injection of Human Subjects with Macrophage Inflammatory Protein-1α Induces Significant Recruitment of Neutrophils and Monocytes 2000 ·The Journal of Immunology ·(unknown), Mary Brummet, Syed Shahabuddin, Thasia Woodworth, Steve N. Georas, Kristin M. Leiferman, Steven C. Gilman, Cristiana Stellato, Ron P. Gladue, Robert P. Schleimer, Lisa A. Beck	85
4	ANTAGONIZING LEUKOTRIENE B4 RECEPTORS DELAYS CARDIAC ALLOGRAFT REJECTION IN MICE 1999 ·Transplantation ·Elora J. Weringer, (unknown), Perry S. Sawyer, Steven C. Gilman, Henry J. Showell	23
5	Modification of monoclonal antibody carbohydrates by oxidation, conjugation, or deoxymannojirimycin does not interfere with antibody effector functions 1994 ·Cancer Immunology Immunotherapy ·Michel Awwad, (unknown), Steven C. Gilman, Helena R. Axelrod	14
6	NATIVE AND SITE SPECIFICALLY CONJUGATED ANTI-CANCER MAb CAN INHIBIT TUMOR GROWTH IN VIVO 1992 ·Journal of Immunotherapy ·Michel Awwad, (unknown), Helena R. Axelrod, Steven C. Gilman	1
7	Carbohydrate-derivatized immunoconjugate of the anti-(carcinoembryonic antigen) monoclonal antibody C46: Immunohistological reactivity and pharmacokinetic comparison with a randomly derivatized C46 immunoconjugate 1990 ·Cancer Immunology Immunotherapy ·Maurice Rosenstraus, Wendy Davis, A. Dwight Lopes, (unknown), Steven C. Gilman	2
8	Development and characterization of monoclonal antibodies with specificity for metallic radioisotope chelators linked to antibodies and other proteins 1989 ·Journal of Immunological Methods ·Ronald W. Gillette, (unknown), (unknown), Steven C. Gilman	8
9	Interleukin‐1 activates phospholipase a₂ IN HUMAN SYNOVIAL CELLS 1988 ·Arthritis & Rheumatism ·Steven C. Gilman, Joseph Chang, (unknown), Joanne Uhl, Eugene Mochan	79
10	Immunological abnormalities in rats with adjuvant-induced arthritis — II. Effect of antiarthritic therapy on immune function in relation to disease development 1987 ·International Journal of Immunopharmacology ·Steven C. Gilman, Richard P. Carlson, (unknown), (unknown), (unknown), Joseph Chang, Alan J. Lewis	23
11	The antiinflammatory activity of the immunomodulator Wy-18,251 (3-(p-chlorophenyl)thiazolo[3,2-a]benzimidazole-2-acetic acid) 1985 ·Inflammation Research ·Steven C. Gilman, Richard P. Carlson, Joseph Chang, Alan J. Lewis	27
12	Effects of Wy-18, 251 (3-(P-Chlorophenyl) Thiazolo [3, 2-A] Benzimidazole-2-Acetic Acid), Levamisole and Indomethacin on the Generation of Murine T Suppressor CellsIn Vitro 1985 ·PubMed ·(unknown), Thomas J. Rogers, Steven C. Gilman	6
13	Immunomodulatory Activity of Wy-18, 251 (3-(P-Chlorophenyl) Thiazolo [3,2-A]Benzimidazole-2-Acetic Acid) 1985 ·PubMed ·Steven C. Gilman, Richard P. Carlson, Alan J. Lewis	16
14	Effects of Oral aspirin and Oxaprozin on the Development of Lupus-Like Disease in Mri/1 Mice 1984 ·PubMed ·Richard P. Carlson, Steven C. Gilman, (unknown), (unknown), (unknown), Alan J. Lewis	5
15	Reaction patterns of herpes simplex virus type 1 and type 2 proteins with sera of patients with uterine cervical carcinoma and matched controls. 1980 ·PubMed ·Steven C. Gilman, John J. Docherty, Aileen Clarke, William E. Rawls	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact